Form D · Biotechnology
Bactana Corp.
Farmington, CT · CIK 0001756999
Offering snapshot reported Jul 7, 2022 · SEC filing
- Reported sold
- $385K Offering amount: $600K
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Jul 1, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 7, 2022 | Initial | $385,000 | No comparison | 8 | SEC filing |
| Feb 5, 2020 | Initial | $25,000 | No comparison | 3 | SEC filing |
| Oct 30, 2018 | Initial | $1,347,100 | No comparison | 20 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-451366
Source: Form D, filed Jul 7, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Rodrigo Bicalho | Director, Executive, Promoter |
| John Kallassy | Director, Executive, Promoter |
| Peter Longo | Director |
| Randolph Seidler | Director |
| Chen Wang | Director |
| David Wurzer | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Cell & Genomics Building 400 Farmington Ave.
Farmington, CT, 06032
Farmington, CT, 06032